Results 251 to 260 of about 312,772 (298)

Comparative costs of subcutaneous and sublingual immunotherapy

Current Opinion in Otolaryngology & Head and Neck Surgery, 2015
This article describes the most recent comparative cost evaluations for subcutaneous (SCIT) and sublingual (SLIT) immunotherapy.Only one recent article compares the costs of SCIT and SLIT in America. No American publications assess direct and indirect costs together.
Christopher, French, Kristin, Seiberling
openaire   +2 more sources

Preventive capacity of subcutaneous immunotherapy

Current Opinion in Allergy and Clinical Immunology, 2002
The scope of this review is to highlight important and interesting articles about the preventive aspects and capacity of allergen-specific subcutaneous injection immunotherapy.There is increasing amount of data that immunotherapy may have a preventive effect in carefully selected patients, both in the development of asthma in patients with allergic ...
openaire   +2 more sources

Pharmacoeconomics of subcutaneous allergen immunotherapy.

European annals of allergy and clinical immunology, 2007
The current burden of allergic diseases, estimated by both direct and indirect costs, is very relevant. In fact the cost estimation for rhinitis amount globally to 4-10 billion dollars/year in the U.S. and to an average annual cost of 1089 euros per child/adolescent and 1543 euros per adult in Europe.
Incorvaia C, Agostinis F, Amoroso S, Ariano R, Barbato A, Bassi M, Cadario G, Campi P, Cardinale F, Romano C, Ciprandi G, D'Anneo R, Dal Bo S, Di Gioacchino M, Fiocchi A, Galimberti M, Galli E, Giovannini M, La Grutta S, Lombardi C, Marcucci F, Marseglia GL, Mastrandrea F, Minelli M, Nettis E, Novembre E, Ortolani C, Pajno G, Piras PP, PASSALACQUA, GIOVANNI, Patriarca G, Pucci S, Quercia O, Romano A, Schiavino D, Sforza M, Tosca MA, Tripodi S, Zambito M, Puccinelli P, Frati F.   +40 more
openaire   +6 more sources

Subcutaneous Injection Immunotherapy for Optimal Effectiveness

Immunology and Allergy Clinics of North America, 2011
Immunotherapy by the subcutaneous injection of increasing doses and then maintenance doses of extracts of inhalant allergens has been practiced for 100 years. Controlled clinical trials have established its efficacy in treating allergic rhinitis, asthma, and stinging insect sensitivity, and there are preliminary data to suggest a favorable response in ...
openaire   +2 more sources

Adherence and cost-effectiveness of subcutaneous immunotherapy and sublingual immunotherapy

2020
Adherence to subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) requires both consistency with scheduled administration and persistence of therapy for a minimum of 3 years to achieve sustained long-term benefit. Reported adherence rates for both forms of allergen immunotherapy (AIT) have, in general, been low but have varied widely ...
Dana V. Wallace, John Oppenheimer
openaire   +1 more source

Subcutaneous Immunotherapy of Food Allergy

Current Allergy and Asthma Reports
While there are compelling arguments for developing subcutaneous allergen-specific immunotherapy for alleviation of food allergies, there is a limited number of studies in the public domain. The review seeks to present the approaches taken, to explain the paucity of studies, and to identify new roads for development.A literature search revealed ...
openaire   +2 more sources

Adherence to imported fire ant subcutaneous immunotherapy

Annals of Allergy, Asthma & Immunology, 2013
Imported fire ant (IFA) subcutaneous immunotherapy (SCIT) is safe and effective. For optimal protection, SCIT is given monthly for 3 to 5 years. Successful outcomes require patient adherence.To evaluate SCIT adherence in IFA allergic patients in an endemic area.Patients with systemic reactions to an IFA sting, with detectable specific IgE, who received
Shayne C, Stokes, James M, Quinn, Joshua J, Sacha, Kevin M, White   +3 more
openaire   +2 more sources

Subcutaneous Immunotherapy Versus Sublingual Immunotherapy: Which Is More Effective?

The Journal of Allergy and Clinical Immunology: In Practice, 2014
Subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are both effective treatments for allergic rhinitis and allergic asthma, both show clinical evidence of disease modification by decreasing new sensitizations in individuals who were monosensitized, by reducing the development of asthma in patients with allergic rhinitis, and by ...
openaire   +2 more sources

Diurnal variations in subcutaneous allergen immunotherapy reactions

Annals of Allergy, Asthma & Immunology, 2017
Circadian rhythms underlie many immune responses and allergic diseases. Subcutaneous immunotherapy (SCIT) can result in adverse reactions; however, it is unclear whether such reactions have a diurnal pattern.To assess whether the timing of SCIT affects the rate of adverse reactions.This study was a retrospective medical record review of adult patients (
Aakash A. Bavishi, Leslie C. Grammer, Jacqueline Pongracic, Karen Rychlik, Rajesh Kumar, Phyllis Zee, Paul A. Greenberger, Anna B. Fishbein   +7 more
openaire   +2 more sources

The Art of Dosing for Subcutaneous Immunotherapy in North America

The Journal of Allergy and Clinical Immunology: In Practice
Subcutaneous immunotherapy (SCIT) is a long-established treatment option for allergic rhinoconjunctivitis. Proper dosing of the allergens is critical for the efficacy and safety of SCIT. Of the hundreds of liquid allergen extracts in the United States, effective and well-tolerated SCIT dosing has only been established for a small number.
Harold S, Nelson, Tricia, Sowers, Greg, Plunkett, Hendrik, Nolte, Karen, Rance   +4 more
openaire   +2 more sources